Contineum Therapeutics, Inc. (CTNM) Current Reports & Earnings Releases
Upcoming
- 2026-10-29 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-07-30 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-13 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-26 | 8-K | Shareholder Vote Results | SEC |
| 2026-05-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-30 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-05 | 8-K | Results of Operations, Other Events, Financial Statements & Exhibits | SEC |
| 2026-01-26 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-12-15 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-12-11 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-20 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-10-30 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-09-18 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-26 | 8-K | Shareholder Vote Results | SEC |
| 2025-05-14 | 8-K | Results of Operations, Other Events, Financial Statements & Exhibits | SEC |
| 2025-04-28 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-03-17 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-03-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-11-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-08-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-06-24 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-05-31 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-05-20 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-05-16 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-04-09 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.